MicuRx Report issue

For profit Phase 1 Phase 3
Founded: Hayward CA United States (2007)

Organization Overview

First Clinical Trial
2015
NCT02269319
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

MicuRx